New EGAPP Recommendation: Genomic Testing to Assess Type 2 Diabetes Risk

The Office of Public Health Genomics (OPHG) provides updated and credible information on how genomic
information and family health history can improve health and influence policy and practice. We highlight
news and information on the use of genomic tests and other applications, including family health history,
in clinical and public health practice and programs, along with relevant data, policy, and legislation. We hope the update is informative to practitioners, policy makers, consumers, and researchers. Please send
your comments to: genetics@cdc.gov. 
New EGAPP Recommendation: Genomic Testing to Assess Type 2 Diabetes Risk

 

• New recommendation from the EGAPP working group: Does genomic profiling to assess type 2 diabetes risk improve health outcomes? Genet Med advance online publication, Mar 14
• EGAPP review: Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review Glenn E. Palomaki et al. Genet Med advance online publication, Mar 14
• CDC fact sheet: Identifying opportunities for using genomic information and family history to improve health and transform healthcare [PDF 1.04 MB]